-
公开(公告)号:WO03020880A2
公开(公告)日:2003-03-13
申请号:PCT/US0224546
申请日:2002-08-02
Applicant: ABBOTT LAB , BORHANI DAVID W , CALDERWOOD DAVID , DIXON RICHARD W , HIRST GAVIN C , HRNCIAR PETER , LOEW ANDREAS , LEUNG ADELAINE , RITTER KURT
Inventor: BORHANI DAVID W , CALDERWOOD DAVID , DIXON RICHARD W , HIRST GAVIN C , HRNCIAR PETER , LOEW ANDREAS , LEUNG ADELAINE , RITTER KURT
CPC classification number: C12N9/1205 , C07K2299/00
Abstract: The present invention relates to polypeptides which comprise the ligand binding domain of Lck, crystalline forms of these polypeptides, and the use of these crystalline forms to determine the three dimensional structure of the catalytic domain of Lck. The invention also relates to the use of the three dimensional structure of the Lck catalytic domain both alone, or in complex with inhibitors, in methods of designing and/or identifying potential inhibitors of Lck activity, for example, compounds which inhibit the binding of a native substrate to the Lck catalytic domain. The invention also relates to the use of the three dimensional structure of the Lck catalytic domain both alone, or in complex with inhibitors, in methods of designing and/or identifying potential selective inhibitors of Lck activity, for example, compounds which inhibit the binding of a native substrate to the Lck catalytic domain selectively.
Abstract translation: 本发明涉及包含Lck的配体结合结构域,这些多肽的结晶形式的多肽以及使用这些结晶形式来确定Lck的催化结构域的三维结构。 本发明还涉及单独或与抑制剂复合的Lck催化结构域的三维结构在设计和/或鉴定潜在的Lck活性抑制剂的方法中的用途,例如抑制 天然底物到Lck催化结构域。 本发明还涉及单独或与抑制剂复合的Lck催化结构域的三维结构在设计和/或鉴定潜在的Lck活性选择性抑制剂的方法中的应用,例如抑制 选择性地将天然底物连接到Lck催化结构域。
-
公开(公告)号:DK1648905T3
公开(公告)日:2009-03-30
申请号:DK04779180
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:CY1111599T1
公开(公告)日:2015-10-07
申请号:CY091100278
申请日:2009-03-12
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Ενώσειςπουέχουντονχημικότύπο: (I), είναιχρήσιμεςγιατηναναστολήκινασώντυροσίνηςπρωτεΐνης. Στηνπαρούσαεφεύρεσηαποκαλύπτονταικαιδημοσιοποιούνταιωςαναφοράεπίσηςμέθοδοιγιατηνπαρασκευήτωνενώσεων, τωνσυνθέσεωνπουπεριέχουντιςενώσεις, καιτωνμεθόδωναγωγήςχρησιμοποιώνταςτιςενώσεις.
-
公开(公告)号:NZ544712A
公开(公告)日:2009-09-25
申请号:NZ54471204
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Disclosed are compounds of formula (I) wherein: X is S; Z is C; R1 and R3 are as described in the specification; and R2 is hydrogen or alkyl. Compounds of the type disclosed are tyrosine kinase inhibitors useful in the treatment of cancer.
-
公开(公告)号:BRPI0412894A
公开(公告)日:2006-10-03
申请号:BRPI0412894
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: A61P35/00 , C07D491/04 , C07D495/04 , C07D498/04 , A61K31/4355 , A61K31/4365
Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:AU2004259765A1
公开(公告)日:2005-02-03
申请号:AU2004259765
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: HRNCIAR PETER , DAVIS HEATHER M , BURCHAT ANDREW F , WADA CAROL K , HEYMAN HOWARD R , HIRST GAVIN C , FREY ROBIN R , RAFFERTY PAUL , CALDERWOOD DAVID J , CURTIN MICHAEL L , MUCKEY MELANIE A , DAVIDSEN STEVEN K , MICHAELIDES MICHAEL R , BETSCHMANN PATRICK
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:PT1648905E
公开(公告)日:2009-04-08
申请号:PT04779180
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: DAVIDSEN STEVEN K , CURTIN MICHAEL L , MICHAELIDES MICHAEL R , BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4353 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/00 , C07D491/04 , C07D495/00 , C07D498/00 , C07D498/04
-
公开(公告)号:CA2532982C
公开(公告)日:2013-11-26
申请号:CA2532982
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula: (I), are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:SI1648905T1
公开(公告)日:2009-06-30
申请号:SI200431056
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/00 , A61K31/00 , A61P35/00 , C07D491/00 , C07D491/04 , C07D495/04 , C07D498/00
-
公开(公告)号:CA2532982A1
公开(公告)日:2005-02-03
申请号:CA2532982
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , HEYMAN HOWARD R , MUCKEY MELANIE A , HIRST GAVIN C , RAFFERTY PAUL , BETSCHMANN PATRICK , HRNCIAR PETER , MICHAELIDES MICHAEL R , BURCHAT ANDREW F , CALDERWOOD DAVID J , WADA CAROL K , FREY ROBIN R
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula: (I), are useful for inhibiting protein tyrosin e kinases. The present invention also discloses methods of making the compound s, compositions containing the compounds, and methods of treatment using the compounds.
-
-
-
-
-
-
-
-
-